MannKind | MNKD - Ordinary Share Capital


MannKind reported $307.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Adma Biologics USD 237.88M 457K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
MannKind USD 307.83M 806K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Novavax USD 162.58M 106K Dec/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Xencor USD 71.87M 529K Dec/2025